Skip to main content

Table 1 Demographical and clinical characteristics of patients

From: Transcriptional response to interferon beta-1a treatment in patients with secondary progressive multiple sclerosis

Groups

RRMS

SPMS

N

35

50

Mean age (years)*

40.2 ± 1.2

52.2 ± 1.1

F (M)

20 (15)

34 (16)

IFN treated (untreated)

10 (25)

20 (30)

Mean EDSS*

2.2 ± 0.2

6.8 ± 0.1

Mean disease duration (years)*

6.8 ± 0.8

18.1 ± 1.4

  1. *p-value <0.05